Greg Moe

Saccharo is a biotech start-up in the immuno-oncology space that develops therapeutic products for the treatment of cancer and other novel diseases. Saccharo discovered a polysaccharide that surrounds human cancer cells. The Sacchario approach has a mechanism of action that allows drugs to have multiple killing effects, a predicted safetyprofile, a broad therapeutic window, and applications to many cancers.Saccharo was established in 2017 by Sherry Martin-Moe and Gregory Moe in Oakland, California.